News

Dec 11th

InorbitTX and Cereno Scientific enter into a licensing agreement

0.jpegInorbitTx and Cereno Scientific announce a licensing agreement for IOT032, now CS036, for cardiovascular diseases.  Please read the full article on BioStock here.

Oct 26th, 2019

InorbitTX presented at the China Biomedical Forum.

Bert Benthem (CEO) was invited to present at the China (Shenzhen) Biomedical Industry Cooperation Forum, Oct 25 – 27 2019 in Shenzhen, China, with key participation from Medical and Pharmaceutical Academia, Presidents of Hospitals and Public Pharmaceuticals, Chairmen of Investment Firms, and Directors of Medical Parks.102A0103.JPG

Oct 9th, 2019

InorbitTX to attend Bio-Europe  in Hamburg, Germany

Robert Judkins(CSO) will attend Bio-Europe, Nov 11 – 13, in Hamburg, Germany.  Robert is happy to meet you there to explore the possibilities for collaborations, alliances, and investment.

Aug 19th, 2019

InorbitTX was invited to present at the China (Rizhao) Biomedical Industry Forum.

Bert Benthem (CEO) was invited to present at the China (Rizhao) Biomedical Industry Cooperation Forum, co-sponsored by the China Biotechnology Association and Beijing Fukangren Bio-Pharma Ltd., on Aug 8th, 2019.

Nov 8th, 2018

InorbitTX covered by Medwatch

InorbitTX got coverage in the Danish biotech and life science media (Medwatch.dk):
‘Tidligere Novo Nordisk-forsker vil opbygge pipeline af fedtlevermidler billigt og hurtigt.’
https://medwatch.dk/Medicinal___Biotek/article10989545.ece